T. Rowe Price Associates »

Trevi Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $47k 14k 3.47

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Fiserv Comm Stk (FI)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
Rubric Capital Management
Viking Global Investors
VR Adviser
Opaleye Management
BlackRock
Vanguard Group
Logos Global Management
MPM Oncology Impact Management
MAI Wealth Advisors
Rosalind Advisors
Geode Capital Management
Landscape Capital Management
Checkpoint Capital

View all funds holding Trevi Therapeutics